SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-19-013702
Filing Date
2019-09-18
Accepted
2019-09-18 10:40:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 30199
2 filename2.txt TEXT-EXTRACT 4797
  Complete submission text file 0000000000-19-013702.txt   47031
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filed for) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)